Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Italian Stock Exchange  >  Reply S.p.A.    REY   IT0005282865

REPLY S.P.A.

(REY)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 12/01 03:59:57 pm
97.25 EUR   +3.79%
11/27REPLY : Reply enters into eSports
BU
11/25Accenture and ION among quartet vying for Italy's Cedacri -sources
RE
11/19REPLY : AXULUS Makes IIoT Projects Scalable
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Reply S p A : Cluster Reply has developed a solution to manage COVID-19 infection chains for the Health Authorities in Bavaria

10/19/2020 | 04:10am EST

19 October 2020

Cluster Reply, the Reply Group company specialised in Microsoft technology, has provided a digital solution to support health authorities in Bavaria in managing COVID-19 infection chains. The aim is to use digitalised processes to contain, trace and interrupt the chains of infection. This results in concrete time savings for the health authorities and valuable support for the most complete traceability possible.

The solution is aimed at health authorities and enables the digital management and administration of people infected with the virus, as well as possible contact persons. The system captures new corona cases via an easy-to-use interface to check known infection chains and identify new outbreaks. This solution enables health authorities to monitor the situation in real time, analyse the dynamics of case spread and take immediate action to identify and contain individual hotspots at an early stage.

Via a self-service portal, which infected persons can access directly after activation by their public health department, they have the opportunity to report their state of health on a daily basis (symptom diary) and report the history of their contact persons. This helps the authorities to recognise the emergence of potential new chains of infection more quickly and take necessary steps to isolate them.

The solution meets the highest security standards for data processing. It is also possible to individually adapt the infection chain management to the needs of a federal state or a municipality.

Disclaimer

Reply S.p.A. published this content on 19 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 October 2020 08:09:05 UTC


© Publicnow 2020
All news about REPLY S.P.A.
11/27REPLY : Reply enters into eSports
BU
11/25Accenture and ION among quartet vying for Italy's Cedacri -sources
RE
11/19REPLY : AXULUS Makes IIoT Projects Scalable
BU
11/12REPLY : The Board of Directors Approves the Quarterly Financial Report as of 30 ..
BU
11/12REPLY S P A : The Board of Directors approves the quarterly financial report as ..
PU
11/12REPLY SPA : The Board of Directors approves the quarterly financial report as of..
EQ
10/22REPLY S P A : Data Reply Achieves AWS Machine Learning Competency Status
BU
10/19REPLY S P A : Cluster Reply has developed a solution to manage COVID-19 infectio..
PU
10/19REPLY : Cluster Reply Has Developed a Solution to Manage COVID-19 Infection Chai..
BU
10/12REPLY : is "Best in Class" Provider of Artificial Intelligence According to tekn..
BU
More news
Financials
Sales 2020 1 242 M 1 496 M 1 496 M
Net income 2020 113 M 137 M 137 M
Net cash 2020 167 M 201 M 201 M
P/E ratio 2020 32,2x
Yield 2020 0,56%
Capitalization 3 657 M 4 370 M 4 405 M
EV / Sales 2020 2,81x
EV / Sales 2021 2,46x
Nbr of Employees 8 540
Free-Float 60,2%
Chart REPLY S.P.A.
Duration : Period :
Reply S.p.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REPLY S.P.A.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Average target price 89,73 €
Last Close Price 97,75 €
Spread / Highest target 7,42%
Spread / Average Target -8,20%
Spread / Lowest Target -32,8%
EPS Revisions
Managers
NameTitle
Mario Rizzante Chairman & Co-Chief Executive Officer
Tatiana Rizzante Co-Chief Executive Officer & Executive Director
Claudio Bombonato Executive Director
Fausto Forti Lead Independent Non-Executive Director
Filippo Rizzante Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
REPLY S.P.A.34.92%4 189
VERISK ANALYTICS32.79%32 243
SAMSUNG SDS CO.,LTD.-11.05%12 078
OTSUKA CORPORATION15.66%9 194
CHANGE HEALTHCARE INC.4.51%5 215
CHINA TRANSINFO TECHNOLOGY CO., LTD8.65%4 711